Rothschild & CO Asset Management Us Inc. Ironwood Pharmaceuticals Inc Transaction History

Rothschild & CO Asset Management Us Inc.

  • $6.56 Billion
  • Q4 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

May 08, 2018
SELL
$11.13 - $13.63 $13.7 Million - $16.7 Million
-1,227,233 Closed
0 $0
Q4 2017

Feb 12, 2018
SELL
$12.16 - $14.58 $464,974 - $557,510
-38,238 Reduced 3.02%
1,227,233 $18.4 Million
Q3 2017

Nov 08, 2017
BUY
$12.07 - $14.87 $15.3 Million - $18.8 Million
1,265,471
1,265,471 $20 Million

Others Institutions Holding IRWD

# of Institutions
247
Shares Held
171M
Call Options Held
11.2M
Put Options Held
28.5K
View Full List

About IRONWOOD PHARMACEUTICALS INC

IRWD Quotes by TradingView
  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $616M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Rothschild & CO Asset Management Us Inc. Portfolio

Follow Rothschild & CO Asset Management Us Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild & CO Asset Management Us Inc., based on Form 13F filings with the SEC.

News

Stay updated on Rothschild & CO Asset Management Us Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email